OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

Published : Thursday, February 2, 2012
OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

OctoPlus N.V. announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company.


The undisclosed contract value will make a material contribution to OctoPlus’ 2012 revenues. Further details on the compound and activities are not disclosed.

At OctoPlus we provide formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. In addition to our expertise in formulation and manufacturing, we offer our clients drug delivery technologies for the development of controlled release versions of existing or new drugs.